Daicel Corporation
Notice Regarding Recording of Extraordinary Loss and Revision of Full-Year Earnings Forecast
Daicel Corporation has recorded approximately 32 billion yen of impairment loss as an extraordinary loss for the fiscal year ending March 2026 and revised its full-year earnings forecast to net sales of 576.0 billion yen, operating income of 41.0 billion yen, and net income attributable to owners of parent of 10.0 billion yen.
Key Figures
- Recorded impairment loss amount: Approximately 32 billion yen
- Net sales forecast for fiscal year ending March 2026: 576,000 million yen (Down 1.2% from previous forecast)
- Net income attributable to owners of parent forecast for fiscal year ending March 2026: 10,000 million yen (Down 80.0% from previous forecast)
AI要約
Revision of Earnings Forecast and Recording of Extraordinary Loss
Daicel Corporation anticipates recognizing an impairment loss of approximately 32 billion yen as an extraordinary loss due to reduced profitability for a new COC resin plant following a review of the business plan. Accordingly, the full-year consolidated earnings forecast for the fiscal year ending March 2026 has been revised downward from the previous forecast of net sales of 583,000 million yen to 576,000 million yen, operating income from 46,500 million yen to 41,000 million yen, and net income attributable to owners of parent from 50,000 million yen to 10,000 million yen.
Background of Revision and Future Outlook
The primary causes of the decline in net sales are delayed inventory adjustments by local manufacturers and plant troubles at the CO facility in the fourth quarter. Additionally, compensation related to the relocation of the engineering plastics business’s China factory has been deferred to the next fiscal year, impacting profit reduction. The startup of the new plant has been postponed from the fourth quarter of the fiscal year ending March 2027 to sometime during the fiscal year ending March 2028, with measures underway to enhance safety and quality. Exchange rates are assumed at 150 yen/US$ and 175 yen/EUR.
Daicel Corporation
Company overview · Stock price · Financial data · All IR